Verified peer comparison
Aktis Oncology vs eXoZymes Financial Comparison
Direct answer
Aktis Oncology and eXoZymes are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Aktis Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Aktis Oncology Revenue
- 6,497,000 USD
- eXoZymes Revenue
- 0 USD
- Aktis Oncology Operating income
- -74,684,000 USD
- eXoZymes Operating income
- -9,716,471 USD